Price Summary

FinStar

Ownership Stable

Ownership strength is slightly missing the benchmark.

ValuationFair

The stock’s market price justifies its intrinsic value.

EfficiencyExcellent

The company knows very well the utilization of its assets.

FinancialsWeak

Watch out! The company might not be able to sustain any adverse condition.

Company Essentials

Market Cap

17139.76 Cr.

Enterprise Value

17399.66 Cr.

Book Value (TTM)

₹  228.49

Your Added Ratios

Please login to Add & View your own added ratios.

Login

 Group Companies

Ratios

Sales Growth

1 Year-9.87%

3 Year-2.94%

5 Year20.13%

Profit Growth

1 Year-28.87%

3 Year-1.39%

5 Year25.42%

ROE%

1 Year12.86%

3 Year20.72%

5 Year22.21%

ROCE %

1 Year14.85%

3 Year24.45%

5 Year26.1%

Interest Cover Ratio

29.3058252427184

CFO/PAT (5 Yr. Avg.)

0.843216120425311

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2021 48.87 0
Mar 2021 48.87 0
Dec 2020 48.91 0
Sep 2020 48.91 0
Jun 2020 48.93 0

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021
Net Sales 532.2 478.9 330.9 311.5 393.8
Total Expenditure 359.6 388.5 252.7 235.1 280.2
Operating Profit 172.6 90.4 78.2 76.4 113.6
Other Income 19.9 27.2 24.9 29.1 12.3
Interest 3.3 2.7 3 2.3 1.8
Depreciation 27.6 28.4 29.4 29.8 33.1
Exceptional Items 0 0 0 0 0
Profit Before Tax 161.6 86.5 70.7 73.4 91
Tax 34.9 15.6 16 16.2 15.8
Profit After Tax 126.7 70.9 54.7 57.2 75.2
Adjusted EPS (Rs) 6.96 3.9 3.01 3.13 4.12

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Net Sales 1021.4 1958 2091.3 1986.3 1790.2
Total Expenditure 740.7 1266 1162.9 1169.8 1212.2
Operating Profit 280.7 692 928.4 816.5 578
Other Income 12.9 13.2 39.4 129.8 123.8
Interest 21.9 17.5 14.7 18.8 20.6
Depreciation 50.2 53.6 65.5 80.1 98.1
Exceptional Items 0 0 0 0 0
Profit Before Tax 221.5 634.1 887.6 847.4 583.1
Tax 45 139.3 189.4 180.3 108.6
Net Profit 176.5 494.8 698.2 667.1 474.5
Adjusted EPS (Rs.) 10.14 28.36 37.84 36.55 26.07

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Equity and Liabilities
Share Capital 34.8 34.9 36.9 36.5 36.4
Total Reserves 1301.5 1664.8 3088.5 3526.7 3833.1
Borrowings 0 0 0 0 0.9
Other N/C liabilities 27.9 37.7 47 83.1 116.6
Current liabilities 478.5 609.7 563.8 709.8 659.7
Total Liabilities 1842.7 2347.1 3736.2 4356.1 4646.7
Assets
Net Block 705.6 829 1015.3 1214.9 1574.5
Capital WIP 211.9 336.2 480 637.5 517.8
Intangible WIP 0 0 0 0 0
Investments 71.7 85.9 101.3 117.6 186.1
Loans & Advances 62 60.4 83.1 110.4 124.3
Other N/C Assets 0.6 0.5 2.3 8.3 4.1
Current Assets 790.9 1035.1 2054.2 2267.4 2239.9
Total Assets 1842.7 2347.1 3736.2 4356.1 4646.7

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Profit from operations 221.5 634.1 887.6 847.4 583.1
Adjustment 81.7 99.8 74.4 12.1 45.2
Changes in Assets & Liabilities -68.5 -281.7 -281.2 14.2 -100.7
Tax Paid -44.8 -122.4 -204.4 -174.9 -105.1
Operating Cash Flow 189.9 329.8 476.4 698.8 422.5
Investing Cash Flow -248.1 -290.6 -1131.1 -645.2 -165
Financing Cash Flow 151.4 -45.6 652 -52.2 -261.1
Net Cash Flow 93.2 -6.4 -2.7 1.4 -3.6

Corporate Actions

Investors Details

PARTICULARS Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021
Public 17.85 18.07 17.88 18.65 21.19
iepf 0.34 0.33 0.33 0.33 0.46
tata aia life insurance c... 0 0 0 0 0
PARTICULARS Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021
FII/DII 33.22 33.03 33.21 32.49 29.94
plenty private equity fii... 1.74 1.74 1.74 1.74 1.74
stichting depositary apg ... 0 0 0 0 0
matthews india fund 0 0 0 0 0
nomura singapore limited 1.7 1.69 1.69 1.69 1.69
mirae asset emerging blue... 1.62 2.56 2.79 3.73 4.06
aditya birla sun life tru... 0 0 0 0 0
east bridge capital maste... 3.5 3.47 3 2.64 0
frankling templeton mutua... 0 0 0 0 0
mirae asset emerging blue... 1.62 2.56 2.79 3.73 4.06
icici prudential pharma h... 2.58 1.77 1.39 1.69 0
teacher retirement system... 1.09 0 0 0 0
qualified insitutional bu... 0 0 0 0 0
sbi healthcare opportunit... 0 0 0 0 0
qualified institutional b... 0.33 0 0 5.93 6.25
sbi contra fund 1.54 0 0 0 0
sbi magnum midcap fund 0 1.41 1.21 1.21 1.21
sundaram mutual fund a/c ... 0 1.01 0 0 0
tata aia life insurance c... 0 2.09 0 0 0
tata retirement savings f... 0 1.25 1.21 0 0
life insurance corporatio... 0 0 1.64 1.64 2.46
qualified instutional buy... 0 0 5.39 0 0
tata aia life insurance c... 0 0 2.13 1.98 1.68
qualified institutional b... 0.33 0 0 5.93 6.25
sbi life insurance co ltd... 0 0 0 1.25 0
foreign institutional inv... 0 0 0 0 0.03

Natco Pharma Stock Price Analysis and Quick Research Report. Is Natco Pharma an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Natco Pharma and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 422.5 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Natco Pharma has a Debt to Equity ratio of 0.0816 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Natco Pharma , the EPS growth was -28.6758550504194 % which is bad for the company.
     
  • Operating profit margin: It determines a companys potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Natco Pharma has OPM of 32.2868953189588 % which is a good sign for profitability.
     
  • ROE: Natco Pharma have a average ROE of 12.8622157165704 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholders fund is used for generating profits.
Brief about Natco Pharma

Say hello

Find us at the office

Chappa- Adamitis street no. 38, 81811 Tripoli, Libya

Give us a ring

Alda Runion
+69 213 130 910
Mon - Fri, 10:00-22:00

Say hello